Construct | Activity (U/mg) | kcat (s−1) | KM (mM) | kcat/KM (mM−1 s−1) |
---|---|---|---|---|
Soluble PML | 63.9 ± 2.5 | 112 ± 12 | 1.77 ± 0.33 | 63.2 ± 0.21 |
Soluble PMLVG | 75.5 ± 3.8 | 59.2 ± 2.9 | 0.234 ± 0.051 | 253 ± 0.22 |
Soluble DLZM4 | 106 ± 2.4 | nd | nd | nd |
Cry3Aa–PML | 3.20 ± 0.34 | 5.89 ± 0.83 | 3.46 ± 0.71 | 1.70 ± 0.24 |
Cry3Aa–PMLVG | 5.86 ± 0.24 | 3.48 ± 0.11 | 0.481 ± 0.048 | 7.24 ± 0.10 |
Cry3Aa–DLZM4 | 0.153 ± 0.028 | nd | nd | nd |
Cry3Aa*–PML | 1.51 ± 0.066 | nd | nd | nd |